Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
This report provides a comprehensive analysis of the market for products and therapies used in the management and treatment of psoriatic arthritis (PsA).
PsA is a chronic inflammatory arthritis that affects individuals with psoriasis, a skin condition characterized by red, scaly patches on the skin. PsA can cause joint pain, stiffness, swelling, and progressive joint damage if left untreated.
The psoriatic arthritis treatment market has witnessed growth due to increased awareness campaigns, educational initiatives, and advancements in diagnostic techniques, leading to early detection and diagnosis of PsA. Effective treatment options are in higher demand, driving the market growth. The Psoriatic Arthritis Treatment Market is forecast to grow at a rate of 7.8% CAGR by 2027.
Market Segmentation
The psoriatic arthritis treatment market is segmented based on drug type, type, route of administration, and geography.
1. Drug Type
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Used as first-line treatment for PsA to manage pain, inflammation, and stiffness.
- Disease-Modifying Antirheumatic Drugs (DMARDs): Slow down the progression of joint damage in PsA and reduce inflammation.
- Biologic Therapies: Target specific molecules involved in the immune response and revolutionized PsA treatment.
2. Type
- Prescription: Medications that require a doctor's prescription.
- Over-the-Counter (OTC): Medications that can be purchased without a prescription.
3. Route of Administration
- Injectable
- Oral
- Topical
4. Geography
- North America
- Europe
- Asia Pacific
- Rest of the World
Key aspects of the psoriatic arthritis treatment market:
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): NSAIDs are commonly used as first-line treatment for PsA to manage pain, inflammation, and stiffness. These medications help reduce symptoms and improve joint function. Over-the-counter NSAIDs like ibuprofen and naproxen, as well as prescription-strength options, are available.
- Disease-Modifying Antirheumatic Drugs (DMARDs): DMARDs are used to slow down the progression of joint damage in PsA and reduce inflammation. Traditional DMARDs, such as methotrexate, sulfasalazine, and leflunomide, may be prescribed. Additionally, targeted synthetic DMARDs like apremilast and Janus kinase (JAK) inhibitors such as tofacitinib and baricitinib have shown efficacy in psoriatic arthritis treatment.
- Biologic Therapies: Biologic drugs are a class of medications that target specific molecules involved in the immune response. Biologics, including tumor necrosis factor (TNF) inhibitors (e.g., etanercept, adalimumab), interleukin (IL)-17 inhibitors (e.g., secukinumab, ixekizumab), and IL-23 inhibitors (e.g., ustekinumab, guselkumab), have revolutionized PsA treatment. These drugs are typically administered by injection or infusion and are used when other treatments have been inadequate.
- Corticosteroids: Corticosteroids, such as prednisone, may be used to provide short-term relief from inflammation and pain in psoriatic arthritis. They are usually administered orally or through injections directly into the affected joints. However, long-term use of corticosteroids is generally avoided due to the potential for side effects.
- Physical Therapy and Exercise: Physical therapy plays a crucial role in managing PsA. It helps improve joint mobility, strengthen muscles, and reduce pain. Exercises, such as range-of-motion exercises and low-impact activities like swimming and cycling, can also be beneficial for maintaining joint function and overall well-being.
Vendor Profiles:
The report profiles leading companies of the psoriatic arthritis treatment market including:
- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Eli Lilly And Company
- Johnson & Johnson
- Merck & Co Inc.
- Mylan N.V
- Novartis AG
- Pfizer Inc.
- UCB S.A
For more information about this report visit https://www.researchandmarkets.com/r/sr166m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
